165 related articles for article (PubMed ID: 8744576)
21. Interleukin-12 decreases human immunodeficiency virus type 1 replication in human macrophage cultures reconstituted with autologous peripheral blood mononuclear cells.
Akridge RE; Reed SG
J Infect Dis; 1996 Mar; 173(3):559-64. PubMed ID: 8627017
[TBL] [Abstract][Full Text] [Related]
22. In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients.
Lucey DR; Pinto LA; Bethke FR; Rusnak J; Melcher GP; Hashemi FN; Landay AL; Kessler HA; Paxton RJ; Grabstein K; Shearer GM
Clin Diagn Lab Immunol; 1997 Jan; 4(1):43-8. PubMed ID: 9008279
[TBL] [Abstract][Full Text] [Related]
23. Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.
De Paoli P; Zanussi S; Simonelli C; Bortolin MT; D'Andrea M; Crepaldi C; Talamini R; Comar M; Giacca M; Tirelli U
J Clin Invest; 1997 Dec; 100(11):2737-43. PubMed ID: 9389737
[TBL] [Abstract][Full Text] [Related]
24. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
25. Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production.
Al-Harthi L; Roebuck KA; Landay A
J Clin Immunol; 1998 Mar; 18(2):124-31. PubMed ID: 9533656
[TBL] [Abstract][Full Text] [Related]
26. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
27. Proinflammatory cytokines inhibit HIV-1(SF162) expression in acutely infected human brain cell cultures.
Lokensgard JR; Gekker G; Ehrlich LC; Hu S; Chao CC; Peterson PK
J Immunol; 1997 Mar; 158(5):2449-55. PubMed ID: 9036996
[TBL] [Abstract][Full Text] [Related]
28. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation.
Navarro J; Punzón MC; Pizarro A; Fernández-Cruz E; Fresno M; Muñoz-Fernández MA
AIDS; 1996 May; 10(5):469-75. PubMed ID: 8724037
[TBL] [Abstract][Full Text] [Related]
29. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
Hashimoto K; Shigeta S; Baba M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
[TBL] [Abstract][Full Text] [Related]
30. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma.
Ahn HJ; Maruo S; Tomura M; Mu J; Hamaoka T; Nakanishi K; Clark S; Kurimoto M; Okamura H; Fujiwara H
J Immunol; 1997 Sep; 159(5):2125-31. PubMed ID: 9278298
[TBL] [Abstract][Full Text] [Related]
31. In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12).
Young JM; Ffrench RA; Clarkson JD; Stewart GJ; Liang T; Tideman RL; Packham D; Fulcher DA; Benson EM
AIDS Res Hum Retroviruses; 2001 Feb; 17(3):233-42. PubMed ID: 11177406
[TBL] [Abstract][Full Text] [Related]
32. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
[TBL] [Abstract][Full Text] [Related]
33. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
[TBL] [Abstract][Full Text] [Related]
34. The cytokines IL-4, IFN-gamma, and IL-12 regulate the development of subsets of memory effector helper T cells in vitro.
Bradley LM; Yoshimoto K; Swain SL
J Immunol; 1995 Aug; 155(4):1713-24. PubMed ID: 7636230
[TBL] [Abstract][Full Text] [Related]
35. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.
Clerici M; Lucey DR; Berzofsky JA; Pinto LA; Wynn TA; Blatt SP; Dolan MJ; Hendrix CW; Wolf SF; Shearer GM
Science; 1993 Dec; 262(5140):1721-4. PubMed ID: 7903123
[TBL] [Abstract][Full Text] [Related]
36. Simian immunodeficiency viruses with defective nef genes show increased susceptibility to the noncytotoxic antiviral activity of CD8+ lymphocytes.
Binninger-Schinzel D; Norley S; Adler HS; Oberg HH; Kurth R
Virology; 2002 Mar; 294(1):209-21. PubMed ID: 11886279
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor beta 2 upregulation.
Jones ML; Young JM; Huang QR; Puls RL; Webber CA; Benson EM
AIDS Res Hum Retroviruses; 2003 Apr; 19(4):283-92. PubMed ID: 12804004
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.
Kinter AL; Bende SM; Hardy EC; Jackson R; Fauci AS
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10985-9. PubMed ID: 7479922
[TBL] [Abstract][Full Text] [Related]
39. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072
[TBL] [Abstract][Full Text] [Related]
40. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
